We are a high-tech enterprise specializing in the research and development, as well as production, of cutting-edge biotechnologies such as colloidal gold and rapid immunodiagnostic technologies. Our company focuses on in vitro diagnostic reagents for heart disease, infections, and related in vitro diagnostic instruments.
Our company integrates product research and development, production, sales, and services, employing top international technical standards. We consistently adhere to the principle of “quality first, pursuing excellence, providing high-quality products and satisfactory services to customers, and continuously improving the quality system.” Our product development is guided by goals of “speed, precision, and compactness,” and we are dedicated to innovating fully automated dry-type immunoassay analyzers compatible with colloidal gold or fluorescence in vitro diagnostic reagents. We have received medical device manufacturing licenses from the drug regulatory authority, the Japanese Ministry of Health, and ISO13485 TUV quality system certification.
The company strictly follows industry standards in designing and constructing clean production facilities, introduces advanced domestic and international production equipment and testing instruments, and establishes production processes with independent intellectual property and international advanced levels. We rigorously adhere to industry management regulations and standards to provide products of the highest quality that satisfy our customers. Our self-developed fully automated dry-type immunoassay analyzer has officially been launched, integrating fluorescence immunoassay and colloidal gold immunoassay systems, achieving multifunctionality. The machine features fully automatic sample addition, dilution, mixing, and detection functions, truly realizing automation in testing.